Lonza Group AG
$570.03
24H
Market Cap
Volume
Supply
Price Chart
About Lonza Group AG - LONN.SW
Lonza Group AG is a Swiss multinational, chemicals and biotechnology company, headquartered in Basel, that focuses on providing products and services to the pharmaceutical, healthcare, and life science industries. They offer a range of services from custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
What are Lonza Group AG's core values and mission statement?
Lonza Group AG's core values have traditionally centered around the concepts of innovation, excellence, and promoting a sustainable future. Their mission is to harness science and technology to serve markets like healthcare and nutrition by creating solutions that promote a healthier environment and enhance the quality of life.
Who founded Lonza Group AG and when?
Lonza Group AG was founded by Albert Meyer in 1897.
Who leads Lonza Group AG?
As of my last update, the CEO of Lonza Group AG is Pierre-Alain Ruffieux. Leadership details may have changed since then, so it's best to check the latest information from the company's official communication for the most current leadership information.
Where is Lonza Group AG located, and what is its base country?
Lonza Group AG is headquartered in Basel, Switzerland, which is also its base country.
On which exchanges is Lonza Group AG traded?
Lonza Group AG is primarily traded on the SIX Swiss Exchange under the ticker symbol LONN.
Historical data
Lonza Group AG (LONN) Price Live Data
The live price of Lonza Group AG (LONN) is $570.03, with a trading volume of 182,561 in the last 24 hours. Wrapstocks updates the LONN price in real-time. Lonza Group AG is down -1.91% in the last 24 hours. The company has a live market cap of $41,108,637,278.53 and a supply of 72,116,603 LONN stocks.
Lonza Group AG (LONN) is traded on Swiss Stock Exchange, and currently, the market is closed; trading will be resumed in 12 hours and 44 minutes.
